Mayo, Progentec to market biomarker tests for autoimmune diseases

Create PDF

December 2023—Mayo Clinic Laboratories announced a strategic collaboration to bring Progentec’s proprietary biomarker blood tests for the management of autoimmune diseases to market. The collaboration aims to increase accessibility for providers and patients across the United States and select global markets.

Mayo Clinic Laboratories, 507-266-5700
Progentec Diagnostics, 833-587-8739